Dexcom | DXCM - هزینه بهره بدهی

قیمت سهام
61.57
تغییر روزانه
-1.13 -1.80%
ماهیانه
-7.88%
سالیانه
-14.08%
Q2 پیش بینی
60.25




هزینه بهره بدهی تغییر دادن تاریخ
Abbott USD 68M 26M 2026-03
Align Technology USD 2M 660K 2023-03
AtriCure USD 1.33M 17K 2025-09
Avanos Medical USD 1.9M 100K 2025-12
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 153M 2M 2025-12
Boston Scientific USD 90M 0 2026-03
Cooper Companies USD 22.4M 2M 2025-12
Dexcom USD 4.7M 0 2025-09
Edwards Lifesciences USD 35.9M 2.7M 2025-12
Globus Medical USD 17K 5.1B 2025-12
Inogen 1.03M 384K 2025-03
Insulet USD 9.2M 2.2M 2025-12
Integra LifeSciences USD 23.67M 953K 2025-12
J&J USD 43M 25M 2026-03
Masimo USD 7.5M 1.3M 2025-12
Medtronic USD 181M 0 2025-12
Merit Medical Systems USD 6.36M 390K 2025-12
Roche Holding CHF 304M 7.5M 2025-06
Solventum Corp USD 51M 13.92B 2025-12
Stryker USD 157M 46.17B 2025-09
Tandem Diabetes Care USD 2.07M 872.58M 2025-12
Teleflex USD 28.15M 3.69M 2025-12
West Pharmaceutical Services USD 1.9M 1.7M 2026-03
Zimmer Biomet Holdings USD 71.9M 3.5M 2025-12